Enhanced aggressiveness of benzopyrene-induced squamous carcinomas in transgenic mice overexpressing the proprotein convertase PACE4 (PCSK6)

Molecular Carcinogenesis

Volumn 54, Issue 10, 2015, Pages 1122-1131

  Bassi, Daniel E ^a   Cenna, Jonathan ^a   Zhang, Jirong ^a   Cukierman, Edna ^a   Klein Szanto, Andres J ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Bezo(a)pyrene; PACE4; PCSK6; Proprotein convertases; Skin carcinogenesis; Squamous cell carcinoma; Tumor progression

Indexed keywords

BENZO[A]PYRENE; PROPROTEIN CONVERTASE PACE4; SERINE PROTEINASE; UNCLASSIFIED DRUG; BENZO[A]PYRENE DERIVATIVE; CARCINOGEN; PCSK6 PROTEIN, MOUSE; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOPHOSPHORYLATION; CANCER GROWTH; CELL INVASION; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; EPIDERMIS; GENE OVEREXPRESSION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SKIN CELL; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE; TUMOR INVASION; ANIMAL; CARCINOGENESIS; CELL LINE; CHEMICALLY INDUCED; DISEASE COURSE; DRUG EFFECTS; METABOLISM; PATHOLOGY; SKIN TUMOR; TUMOR CELL LINE;

ANIMALS; BENZOPYRENES; CARCINOGENESIS; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; EPIDERMIS; MICE; MICE, TRANSGENIC; PROPROTEIN CONVERTASES; RECEPTOR, IGF TYPE 1; SKIN NEOPLASMS;

EID: 84941649635     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22183     Document Type: Article

References (53)

1. Steiner DF. The proprotein convertases. Curr Opin Chem Biol 1998; 2:31-39.
2. Seidah NG, Day R, Marcinkiewicz M, Chretien M. Precursor convertases: An evolutionary ancient, cell-specific, combinatorial mechanism yielding diverse bioactive peptides and proteins. Ann N Y Acad Sci 1998; 839:9-24.
3. Seidah NG, Chretien M. Proprotein and prohormone convertases: A family of subtilases generating diverse bioactive polypeptides. Brain Res 1999; 848:45-62.
4. Bassi DE, Mahloogi H, Klein-Szanto AJ. The proprotein convertases furin and PACE4 play a significant role in tumor progression. Mol Carcinog 2000; 28:63-69.
5. Molloy SS, Bresnahan PA, Leppla SH, Klimpel KR, Thomas G. Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem 1992; 267:16396-16402.
6. Seidah NG, Benjannet S, Wickham L, et al. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration, neuronal differentiation. Proc Natl Acad Sci USA 2003; 100:928-933.
7. Seidah NG, Chretien M. Eukaryotic protein processing: Endoproteolysis of precursor proteins. Curr Opin Biotechnol 1997; 8:602-607.
8. Toure BB, Munzer JS, Basak A, et al. Biosynthesis and enzymatic characterization of human SKI-1/S1P and the processing of its inhibitory prosegment. J Biol Chem 2000; 275:2349-2358.
9. Tsuji A, Sakurai K, Kiyokage E, et al. Secretory proprotein convertases PACE4 and PC6A are heparin-binding proteins which are localized in the extracellular matrix. Potential role of PACE4 in the activation of proproteins in the extracellular matrix. Biochim Biophys Acta 2003; 1645:95-104.
10. Tsuji A, Hashimoto E, Ikoma T, et al. Inactivation of proprotein convertase, PACE4, by alpha1-antitrypsin Portland (alpha1-PDX), a blocker of proteolytic activation of bone morphogenetic protein during embryogenesis: Evidence that PACE4 is able to form an SDS-stable acyl intermediate with alpha1-PDX. J Biochem 1999; 126:591-603.
11. Yuasa K, Masuda T, Yoshikawa C, Nagahama M, Matsuda Y, Tsuji A. Subtilisin-like proprotein convertase PACE4 is required for skeletal muscle differentiation. J Biochem 2009; 146:407-415.
12. Dubois CM, Blanchette F, Laprise MH, Leduc R, Grondin F, Seidah NG. Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme. Am J Pathol 2001; 158:305-316.
13. Yana I, Weiss SJ. Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol Biol Cell 2000; 11:2387-2401.
14. Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 1996; 393:101-104.
15. Khatib AM, Siegfried G, Prat A, et al. Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells: Importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions. J Biol Chem 2001; 276:30686-30693.
16. Hubbard FC, Goodrow TL, Liu SC, et al. Expression of PACE4 in chemically induced carcinomas is associated with spindle cell tumor conversion and increased invasive ability. Cancer Res 1997; 57:5226-5231.
17. Bassi DE, Lopez De Cicco R, Cenna J, Litwin S, Cukierman E, Klein-Szanto AJ. PACE4 expression in mouse basal keratinocytes results in basement membrane disruption and acceleration of tumor progression. Cancer Res 2005; 65:7310-7319.
18. Fu J, Bassi DE, Zhang J, et al. Enhanced UV-induced skin carcinogenesis in transgenic mice overexpressing proprotein convertases. Neoplasia 2013; 15:169-179. PMCID: 3579319.
19. Shimkin MB, Triolo VA. History of chemical carcinogenesis: Some prospective remarks. Prog Exp Tumor Res 1969; 11:1-20.
20. DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmacol Ther 1992; 54:63-128.
21. Slaga TJ. Overview of tumor promotion in animals. Environ Health Perspect 1983; 50:3-14.
22. Hecht SS. Cigarette smoking and lung cancer: Chemical mechanisms and approaches to prevention. Lancet Oncol 2002; 3:461-469.
23. Denissenko MF, Pao A, Tang M, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 1996; 274:430-432.
24. Yoshino I, Kometani T, Shoji F, et al. Induction of epithelial-mesenchymal transition-related genes by benzo[a]pyrene in lung cancer cells. Cancer 2007; 110:369-374.
25. Siddens LK, Larkin A, Krueger SK, et al. Polycyclic aromatic hydrocarbons as skin carcinogens: Comparison of benzo[a]pyrene, dibenzo[def, p]chrysene and three environmental mixtures in the FVB/N mouse. Toxicol Appl Pharmacol 2012; 264:377-386. PMCID:3483092.
26. Nesnow S, Gold A, Sangaiah R, Slaga TJ. Mouse skin tumor-initiating activity of benz[j]aceanthrylene in SENCAR mice. Cancer Lett 1993; 73:73-76.
27. Nesnow S, Triplett LL, Slaga TJ. Studies on the tumor initiating, tumor promoting, and tumor co-initiating properties of respiratory carcinogens. Carcinog Compr Surv 1985; 8:257-277.
28. Slaga TJ, Bracken WM, Dresner S, et al. Skin tumor-initiating activities of the twelve isomeric phenols of benzo(a)pyrene. Cancer Res 1978; 38:678-681.
29. Slaga TJ, Fischer SM, Weeks CE, Klein-Szanto AJ. Multistage chemical carcinogenesis in mouse skin. Curr Probl Dermatol 1980; 10:193-218.
30. Park NH, Gujuluva CN, Baek JH, Cherrick HM, Shin KH, Min BM. Combined oral carcinogenicity of HPV-16 and benzo(a)pyrene: An in vitro multistep carcinogenesis model. Oncogene 1995; 10:2145-2153.
31. Mitsunaga S, Clapper M, Litwin S, Watts P, Bauer B, Klein-Szanto AJ. Chemopreventive effect of difluoromethylornithine (DFMO) on mouse skin squamous cell carcinomas induced by benzo(a)pyrene. J Cell Biochem Suppl 1997; 28-29:81-89.
32. Ruggeri B, DiRado M, Zhang SY, Bauer B, Goodrow T, Klein-Szanto AJ. Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene. Proc Natl Acad Sci USA 1993; 90:1013-1017.
33. Guttenplan JB, Kosinska W, Zhao ZL, et al. Mutagenesis and carcinogenesis induced by dibenzo[a, l]pyrene in the mouse oral cavity: A potential new model for oral cancer. Int J Cancer 2012; 130:2783-2790.
34. Bassi DE, Klein-Szanto AJ. Carcinogen-induced animal models of head and neck squamous cell carcinoma. Curr Protoc Pharmacol 2007; Chapter 14:Unit 142.
35. Zhao P, Fu J, Yao B, et al. In vitro malignant transformation of human bronchial epithelial cells induced by benzo(a)pyrene. Toxicol In Vitro 2012; 26:362-368.
36. Iizasa T, Momiki S, Bauer B, et al. Invasive tumors derived from xenotransplanted, immortalized human cells after in vivo exposure to chemical carcinogens. Carcinogenesis 1993; 14:1789-1794.
37. Sellakumar AR, Montesano R, Saffiotti U, Kaufman DG. Hamster respiratory carcinogenesis induced by benzo(a)pyrene and different dose levels of ferric oxide. J Natl Cancer Inst 1973; 50:507-510.
38. Ashurst SW, Cohen GM, Nesnow S, DiGiovanni J, Slaga TJ. Formation of benzo(a)pyrene/DNA adducts and their relationship to tumor initiation in mouse epidermis. Cancer Res 1983; 43:1024-1029.
39. Walaszek Z, Hanausek M, Slaga TJ. The role of skin painting in predicting lung cancer. Int J Toxicol 2007; 26:345-351.
40. Saffiotti U, Montesano R, Sellakumar AR, Cefis F, Kaufman DG. Respiratory tract carcinogenesis in hamsters induced by different numbers of administrations of benzo(a)pyrene and ferric oxide. Cancer Res 1972; 32:1073-1081.
41. Saffiotti U, Montesano R, Sellakumar AR, Kaufman DG. Respiratory tract carcinogenesis induced in hamsters by different dose levels of benzo-(a)pyrene and ferric oxide. J Natl Cancer Inst 1972; 49:1199-1204.
42. Mahloogi H, Bassi DE, Klein-Szanto AJ. Malignant conversion of non-tumorigenic murine skin keratinocytes overexpressing PACE4. Carcinogenesis 2002; 23:565-572.
43. Ruggeri BA, Bauer B, Zhang SY, Klein-Szanto AJ. Murine squamous cell carcinoma cell lines produced by a complete carcinogenesis protocol with benzo[a]pyrene exhibit characteristic p53 mutations and the absence of H-ras and cyl 1/cyclin D1 abnormalities. Carcinogenesis 1994; 15:1613-1619.
44. Bassi DE, Zhang J, Cenna J, Litwin S, Cukierman E, Klein-Szanto AJ. Proprotein convertase inhibition results in decreased skin cell proliferation, tumorigenesis, and metastasis. Neoplasia 2010; 12:516-526.
45. Lopez de Cicco R, Watson JC, Bassi DE, Litwin S, Klein-Szanto AJ. Simultaneous expression of furin and vascular endothelial growth factor in human oral tongue squamous cell carcinoma progression. Clin Cancer Res 2004; 10:4480-4488.
46. Khatib AM, Siegfried G, Prat A, et al. Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells-Importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions. J Biol Chem 2001; 276:30686-30693.
47. Bassi DE, Mahloogi H, De Cicco RL, Klein-Szanto A. Increased furin activity enhances the malignant phenotype of human head and neck cancer cells. Am J Pathol 2003; 162:439-447.
48. Mahloogi H, Gonzalez-Guerrico AM, Lopez De Cicco R, et al. Overexpression of the calcium sensor visinin-like protein-1 leads to a cAMP-mediated decrease of in vivo and in vitro growth and invasiveness of squamous cell carcinoma cells. Cancer Res 2003; 63:4997-5004.
49. Angliker H. Synthesis of tight binding inhibitors and their action on the proprotein-processing enzyme furin. J Med Chem 1995; 38:4014-4018.
50. Sachdev D, Hartell JS, Lee AV, Zhang X, Yee D. A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells. J Biol Chem 2004; 279:5017-5024.
51. Cheng ZQ, Adi S, Wu NY, et al. Functional inactivation of the IGF-I receptor delays differentiation of skeletal muscle cells. J Endocrinol 2000; 167:175-182.
52. Kawashima Y, Kanzaki S, Yang F, et al. Mutation at cleavage site of insulin-like growth factor receptor in a short-stature child born with intrauterine growth retardation. J Clin Endocrinol Metab 2005; 90:4679-4687.
53. Couture F, D'Anjou F, Desjardins R, Boudreau F, Day R. Role of proprotein convertases in prostate cancer progression. Neoplasia 2012; 14:1032-1042.